Article info

Download PDFPDF

Targeting the indoleamine 2,3-dioxygenase pathway in cancer

Authors

  • Yong Wha Moon Medical Oncology, Department of Internal Medicine, CHA Bundang Medical CenterCHA University 463-712 Seongnam-si Gyeonggi-do South Korea Department of Investigational Cancer TherapeuticsThe University of Texas MD Anderson Cancer Center Box 455 1515 Holcombe Blvd 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Joud Hajjar Section of Immunology, Allergy & Rheumatology, Baylor College of MedicineTexas Children’s Hospital 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Patrick Hwu Department of Melanoma Medical OncologyThe University of Texas MD Anderson Cancer Center 77030 Houston TX USA PubMed articlesGoogle scholar articles
  • Aung Naing Department of Investigational Cancer TherapeuticsThe University of Texas MD Anderson Cancer Center Box 455 1515 Holcombe Blvd 77030 Houston TX USA PubMed articlesGoogle scholar articles
  1. a doctormoon7{at}gmail.com
  2. b joud.hajjar{at}bcm.edu
  3. c phwu{at}mdanderson.org
  4. d (713) 792-2950 anaing{at}mdanderson.org
View Full Text

Citation

Moon YW, Hajjar J, Hwu P, et al
Targeting the indoleamine 2,3-dioxygenase pathway in cancer

Publication history

  • Received July 9, 2015
  • Accepted October 13, 2015
  • First published December 15, 2015.
Online issue publication 
February 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.